Citius pharmaceuticals ceo myron holubiak featured in benzinga interview

Cranford, n.j., april 22, 2021 /prnewswire/ -- citius pharmaceuticals, inc. ("citius" or the "company") (nasdaq: ctxr), a specialty pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infective products in adjunct cancer care, unique prescription products and stem cell therapy, today announced that citius president and ceo, myron holubiak, was featured in an interview with benzinga discussing the company's product pipeline, the impact of covid-19, and upcoming milestones.
CTXR Ratings Summary
CTXR Quant Ranking